[{"type": "title", "data": "ORTHO Fractured Hip Venous Thromboembolism (VTE) Prophylaxis"}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "For patients awaiting emergency surgery, administer once/twice daily LMWH dosing as planned if surgery is cancelled and pushed to the following day, no later than 1900h"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "Monitor patients with epidural catheter receiving anticoagulant prophylaxis for symptoms and signs of spinal hematoma"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Pharmacologic prophylaxis for patients not requiring epidural / perineural analgesia"}, {"type": "order", "data": "Hold Medication(s)", "value": ""}, {"type": "sentence", "data": "Clinical event: Planned Surgery, Medication(s) to be held: enoxaparin, Instructions: Do not administer enoxaparin if surgery is planned within the next 12 hours"}, {"type": "note", "data": "Do not remove epidural / perineural catheter for at least 12 hours after the last dose of LMWH (enoxaparin) or at least 4 hours after the last dose of heparin&nbsp; After catheter removal, do not administer LMWH (enoxaparin) for at least 4 hours or heparin for at least 1 hour "}, {"type": "note", "data": "Epidural contraindicated if enoxaparin dose exceeds 40 mg daily. Prescriber to order alternate anticoagulant if needed"}, {"type": "note", "data": "Enoxaparin for eGFR 30 mL/min or greater"}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "30 mg, SubQ, Injection, q24hr(sched), 180 day(s)"}, {"type": "sentence", "data": "30 mg, SubQ, Injection, qAM, 180 day(s)"}, {"type": "sentence", "data": "40 mg, SubQ, PFS, q24hr(sched), 180 day(s)"}, {"type": "sentence", "data": "40 mg, SubQ, Injection, qAM, 180 day(s)"}, {"type": "sentence", "data": "40 mg, SubQ, Injection, q12hr(sched), 180 day(s)"}, {"type": "sentence", "data": "60 mg, SubQ, Injection, q12hr(sched), 180 day(s)"}, {"type": "note", "data": "Enoxaparin for eGFR 10 to 29 mL/min"}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "30 mg, SubQ, Injection, q24hr(sched), 180 day(s)"}, {"type": "sentence", "data": "30 mg, SubQ, Injection, qAM, 180 day(s)"}, {"type": "sentence", "data": "40 mg, SubQ, PFS, q24hr(sched), 180 day(s)"}, {"type": "sentence", "data": "40 mg, SubQ, PFS, qAM, 180 day(s)"}, {"type": "sentence", "data": "60 mg, SubQ, Injection, q24hr(sched), 180 day(s)"}, {"type": "sentence", "data": "60 mg, SubQ, Injection, qAM, 180 day(s)"}, {"type": "note", "data": "Heparin for eGFR less than 10 mL/min or on dialysis"}, {"type": "order", "data": "heparin", "value": ""}, {"type": "sentence", "data": "2,500 unit(s), SubQ, Injection, q12hr(sched), 180 day(s)"}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, q12hr(sched), 180 day(s)"}, {"type": "sentence", "data": "5,000 unit(s), SubQ, Injection, q8hr(sched), 180 day(s)"}, {"type": "note", "data": "For low risk post operative patients only, on mechanical prophylaxis"}, {"type": "order", "data": "ASA 81 mg oral delayed release tablet", "value": ""}, {"type": "sentence", "data": "162 mg, PO, q24hr, 180 day(s)"}, {"type": "note", "data": "VTE RISK IS MODERATE OR HIGH WITH CONTRAINDICATION TO ANTICOAGULANTS"}, {"type": "note", "data": "Mechanical prophylaxis contraindicated in:&nbsp; -Peripheral vascular disease with absent pedal pulses -Severe peripheral neuropathy -Skin breakdown, ulcers, gangrene, cellulitis, or dermatitis&nbsp; -Skin grafting within last 3 months&nbsp; -Allergy to stocking or compression cuff materials&nbsp; -Unable to size or apply properly due to deformity, recent surgery or trauma&nbsp; -Acute stroke with immobility (unable to walk independently to the toilet) should not use graduated compression stockings or calf-length / below the knee Sequential Compression Devices. Thigh-length / full leg Sequential Compression Device should be utilized"}, {"type": "order", "data": "Anti-embolism Stocking", "value": ""}, {"type": "sentence", "data": "T;N, Below the knees - apply continuously until anticoagulant prophylaxis starts or patient discharge. Interrupt for skin care, assessments, toileting, and ambulation only"}, {"type": "order", "data": "Sequential Compression Device (SCD) Application", "value": ""}, {"type": "sentence", "data": "T;N, Full legs - apply continuously until anticoagulant prophylaxis starts or discharge. Interrupt for skin care, assessments, toileting, and ambulation only"}, {"type": "order", "data": "Sequential Compression Device (SCD) Application", "value": ""}, {"type": "sentence", "data": "T;N, Below the knee - apply continuously until anticoagulant prophylaxis starts or discharge. Interrupt for skin care, assessments, toileting, and ambulation only"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "T;N, No mechanical prophylaxis because of contraindication(s)"}, {"type": "note", "data": "VTE RISK IS LOW "}, {"type": "order", "data": "Ambulate", "value": ""}, {"type": "sentence", "data": "T;N, Early ambulation; no anticoagulant or no mechanical prophylaxis required"}, {"type": "note", "data": "VTE RISK IS MODERATE OR HIGH "}, {"type": "note", "data": "Order pharmacologic prophylaxis except when:&nbsp; - Active bleeding of clinical significance requiring intervention&nbsp;&nbsp; - High risk of serious bleeding or bleeding into a critical site (e.g. intracranial, epidural, pericardial, intraocular, retroperitoneal, intra-articular)&nbsp;&nbsp; - Known major bleeding disorder or acquired coagulopathy (consider Hematology consult)&nbsp; - Platelet count less than 50 x 10^9/L (consider Hematology consult)&nbsp;&nbsp; - If history of Heparin-Induced Thrombocytopenia (HIT), DO NOT give LMWH or heparin. Consider fondaparinux or consult Hematology / Internal Medicine for use of an alternative agent if eGFR less than 30 mL/min&nbsp; - Patient already receiving therapeutic anticoagulation"}, {"type": "note", "data": "<P>Placeholder: VTE Prophylaxis Contraindication</P>"}, {"type": "note", "data": "Reassess daily to start anticoagulant prophylaxis when contraindication resolves "}, {"type": "note", "data": "Refer to VTE Risk Assessment and Thromboprophylaxis Recommendation"}]
